Resistance of Foxp3+ Regulatory T Cells to Nur77-Induced Apoptosis Promotes Allograft Survival
Ran Tao, Wayne W. Hancock · 2008
Read Resistance of Foxp3+ Regulatory T Cells to Nur77-Induced Apoptosis Promotes Allograft Survival by Ran Tao, Wayne W. Hancock (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0002321.txt.
Introduction
Ran Tao and Wayne Hancock studied why one class of T cells resists a death signal, in a 2008 PLOS ONE paper. Nur77 is a nuclear receptor that pushes young T cells to die during the selection that removes self-reactive cells. It may also act in mature T cells out in the body. Regulatory T cells, marked by Foxp3, are the immune system's peacekeepers.
The team reports that these regulatory cells resist Nur77-induced apoptosis, and that the resistance promotes the survival of transplanted organs in their models. If peacekeeper cells are built to survive death signals, boosting that trait might help transplants last without heavy drugs.
Catalog record
| CREATOR | Ran Tao, Wayne W. Hancock |
|---|---|
| YEAR | 2008 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0002321
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Resistance of Foxp3+ Regulatory T Cells to Nur77-Induced Apoptosis Promotes Allograft Survival Authors: Ran Tao, Wayne W. Hancock Published: 2008, PLOS ONE DOI: 10.1371/journal.pone.0002321 ABSTRACT The NR4A nuclear receptor family member Nur77 (NR4A1) promotes thymocyte apoptosis during negative selection of autoreactive thymocytes, but may also function in mature extrathymic T cells. We studied the effects of over-expression of Nur77 on the apoptosis of murine peripheral T cells, including thymic-derived Foxp3+ regulatory (Treg) cells. Overexpression of Nur77 in the T cell lineage decreased numbers of peripheral CD4 and CD8 T cells by ∼80% compared to wild-type (WT) mice. However, the proportions of Treg cells were markedly increased in the thymus (61% of CD4+Foxp3+ singly positive thymocytes vs. 8% in WT) and secondary lymphoid organs (40–50% of CD4+Foxp3+ T cells vs. 7–8% in WT) of Nur77 transgenic (Nur77Tg) mice, and immunoprecipitation studies showed Nur77 was associated with a recently identified HDAC7/Foxp3 transcriptional complex. Upon activation through the T cell receptor in vitro or in vivo, Nur77Tg T cells showed only marginally decreased proliferation but significantly increased apoptosis. Fully allogeneic cardiac grafts transplanted to Nur77Tg mice survived long-term with well-preserved structure, and recipient splenocytes showed markedly enhanced apoptosis and greatly reduced anti-donor recall responses. Allografts in Nur77Tg recipients had significantly increased expression of multiple Treg-associated genes, including Foxp3, Foxp1, Tip60 and HDAC9. Allograft rejection was restored by CD25 monoclonal antibody therapy, indicating that allograft acceptance was dependent upon Treg function in Nur77Tg recipients. These data show that compared to conventional CD4 and CD8 T cells, Foxp3+ Tregs are relatively resistant to Nur77-mediated apoptosis, and that tipping the balance between the numbers of Tregs and responder T cells in the early period post-transplantation can determine the fate of the allograft. Hence, induced expression of Nur77 might be a novel means to achieve long-term allograft survival. INTRODUCTION Nur77 (also known as NR4A1, TR3, NGFI-B or NAK1) is an inducible orphan nuclear receptor comprised of an N-terminal AF1 transactivation domain, a DNA binding domain containing two zinc fingers, and a C-terminal ligand binding domain. Nur77 is necessary for induction of apoptosis in T-cell hybridomas [1] , [2] and constitutive expression of Nur77 in thymocytes and various cell lines leads to apoptosis [3] , [4] . In vivo, transgenic mice expressing dominant-negative Nur77 are defective in the process of negative selection whereas positive selection proceeds normally [3] , [5] . However, Nur77-deficient mice are phenotypically normal, suggesting functional redundancy between Nur77 and related proteins [6] . Aspects of the mechanism by which Nur77 induces cell apoptosis remain unclear. In resting thymocytes, Nur77 expression is inhibited by the histone deacetylase, HDAC7 [7] . T cell receptor (TCR) activation induces HDAC7 phosphorylation by the serine/threonine kinase PKD1, and phosphorylated HDAC7 binds to 14-3-3 protein and is exported from the nucleus, leading to depression of Nur77 and other gene targets [7] – [10] . However, Nur77 downstream target genes responsible for regulating T cell apoptosis remain to be identified. Although expression levels of FasL and CD30 are elevated in Nur77 transgenic mice [4] , Nur77-mediated apoptosis is still intact in gld/gld (FasL mutant mice) or CD30−/− mice, precluding FasL and CD30 as the major downstream effectors of Nur77-related apoptosis in thymocytes [11] . Moreover, negative selection of CD4+CD8+ doubly-positive thymocytes is intact in Fas- or CD30-deficient mice, and constitutive expression of Nur77 in gld/gld mice rescues the lymphoproliferative phenotype of the FasL mutant mice [12] , [13] . In tumor cell lines, Nur77 initiates apoptosis by translocating to the mitochondria, leading to release of cytochrome c [14] , [15] , activation of Apaf-1 and caspase-9, cleavage of pro-caspase 3 and induction of apoptosis [16] . Over-expression of Bcl-2 does not block Nur77-mediated apoptosis in T cells [11] , suggesting that either Nur77 transcription plays an especially prominent role in initiating apoptosis in T cells or that Nur77 initiates a Bcl-2-independent mitochondrial apoptotic pathway. Indeed, recent microarray studies showed Nur77 induces known apoptotic genes such as FasL and TRAIL, but also novel genes such as NDG1 and NDG2 that promote apoptosis in a Bcl-2-independent manner [17] . In addition to promoting cell apoptosis through the mechanisms outlined above, Nur77 can also function as an inhibitor of protein kinase C (PKC) [18] . The C-terminal ligand-binding domain of Nur77 can specifically interact with the highly conserved glycine-rich loop of PKC-theta that is required for its catalytic activity, preventing the phosphorylation of substrate by PKC-theta. Hence, inhibition of catalytic activity by Nur77 can repress PKC-mediated activation of AP-1 and NF-κB, with multiple downstream effects including preventing induction of anti-apoptotic genes. All these findings suggest an essential role of Nur77 in apoptotic death accompanying negative selection in thymocyte development. However, the role of Nur77 in induction of apoptosis in mature T cells, and in the induction and/or maintenance of peripheral tolerance is only poorly understood. Likewise, there are no data as to the effects of Nur77 on the apoptosis of thymic-derived Foxp3+ regulatory T (Treg) Treg vs. non-Treg cells. In the current study, we evaluated the role of Nur77 on peripheral T cell apoptosis by taking advantage of transgenic mice in which Nur77 was overexpressed in thymocytes and T cells using the Lck promoter. RESULTS We found by quantitative real-time PCR (qPCR), that expression of the inducible immediate early gene, Nur77, was upregulated within 4 h of in vitro stimulation by PMA/ionomycin ( Figure 1a ) or CD3 monoclonal antibody (mAb) ( Figure 1b ), and returned to basal levels by 24 h in both non-Tregs and Tregs (p>0.05). Using immunoprecipitation, we found that Nur77 formed a complex with HDAC7 and Foxp3 in resting Tregs ( Figure 1c ), similarly to that of HDAC7 and Foxp3 [19] , and intranuclear staining for Nur77 protein showed that Nur77 was expressed by a small population of naive CD4+ T cells, especially CD4+ Foxp3+ T cells, but not by naive CD8+ T cells ( Figure 1d ). After 24 h of in vitro stimulation, both CD4+ and CD8+ T cells showed increased Nur77 protein expression, though levels of expression were less than in CD4+ Foxp3+ T cells. Nur77 was not expressed by CD19+ B cells, CD11b+ macrophages, CD11c+ dendritic cells or NK1.1+ natural killer cells, regardless of LPS stimulation ( Figure 1d ). (a) Nur77 mRNA expression after T cell activation using PMA/ionomycin or (b) CD3 mAb as shown by qPCR analysis of CD4+CD25− and CD4+CD25+ T cells; data expressed as fold increases (mean±SD) above control set as 1. Nur77 expression at 4 h was comparable (p>0.05) for Tregs and non-Tregs, but significantly increased compared to levels either at rest or after 24 h of activation (*p<0.01). (c) Nur77 forms a complex with HDAC7 and Foxp3 as shown by immunoprecipitation of HDAC7 from splenocytes, followed by SDS-PAGE and Western blotting with mAb to Foxp3 or Nur77. (d) Nur77 is mainly expressed by T cells upon activation, especially by CD4+Foxp3+ Tregs, as shown by splenocytes stimulated with PMA/ionomycin or LPS for 24 h, followed by staining with cell markers, and mAbs to Foxp3 and Nur77, or isotype controls (grey). Data are representative of 2 experiments with similar results. (e) Altered thymocyte development, decreased peripheral T cell populations and expanded proportion of CD4+Foxp3+ fraction in Nur77Tg mice. Thymuses from